BackTable / Urology / Podcast / Episode #54

Smoking Cessation for the Urologist

with Dr. Christian Fankhauser and Dr. Richard Matulewicz

In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses methods and benefits of smoking cessation in urologic oncology patients with Dr. Christian Fankhauser from Luzerner Kantonsspital and Dr. Richard Matulewicz from Memorial Sloan Kettering.

Smoking Cessation for the Urologist with Dr. Christian Fankhauser and Dr. Richard Matulewicz on the BackTable Urology Podcast)
Ep 54 Smoking Cessation for the Urologist with Dr. Christian Fankhauser and Dr. Richard Matulewicz
00:00 / 01:04

BackTable, LLC (Producer). (2022, September 14). Ep. 54 – Smoking Cessation for the Urologist [Audio podcast]. Retrieved from

Earn CME

Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs.
Follow the button below to get started with CMEfy.

BackTable CMEfy button

Stay Up To Date



Sign Up:

Podcast Contributors

Dr. Christian Fankhauser discusses Smoking Cessation for the Urologist on the BackTable 54 Podcast

Dr. Christian Fankhauser

Dr. Christian Fankhauser is a urologist at Luzerner Kantonsspital in Switzerland.

Dr. Richard Matulewicz discusses Smoking Cessation for the Urologist on the BackTable 54 Podcast

Dr. Richard Matulewicz

Dr. Richard Matulewicz is a urologic oncologist and surgeon at Memorial Sloan Kettering Cancer Center in New York City.

Dr. Aditya Bagrodia discusses Smoking Cessation for the Urologist on the BackTable 54 Podcast

Dr. Aditya Bagrodia

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Show Notes

First, the doctors discuss the role of urologists in taking charge of smoking cessation. Because smoking cessation directly minimizes surgical complication and increases longevity in urologic oncology patients. It is beneficial to have other medical professionals, such as physicians in other specialties (e.g. cardiology) and PAs, working to encourage smoking cessation as well.

Next, they discuss the initial intake of a smoking patient. Screening patients for smoking is not happening as commonly as it should. Additionally, it is important to use non-judgmental phrasing and tone in order to make the patient feel comfortable with sharing information. When screening for smoking, the 5A Model can be used: ask, advise, assess, assist, and arrange smoking cessation therapy. However, this method can take up a lot of time during the clinic visit. Thus, pre-visit questionnaires are efficient. When counseling a patient to quit smoking, it is best to set a quit date within 2-3 weeks before surgery. Some evidence-based benefits to smoking cessation include: inhibition of bladder cancer progression, increases in longevity, minimizing perioperative complications, prevention of erectile dysfunction and infertility, and the promotion of wound healing. Dr. Bagrodia also mentions that bladder treatment outcomes from adjuvant chemotherapy and intravesical therapy will improve with cessation. Some common cessation techniques are nicotine replacement therapy and stress reduction techniques.

The urologist can take the lead on smoking cessation or refer the patient to a counselor. In Europe, Dr. Fankhauser sends the patient to their general practitioner to initiate cessation therapy, while Dr. Matulewicz encourages urologists to learn how to document cessation encouragement as a separate billable service. Finally, the doctors share resources for urologists wanting to help their patients quit smoking. All three urologists agree that there should be more formal education initiatives about cessation for medical students and residents and that society guidelines should emphasize the importance of smoking cessation more strongly. Dr. Matulewicz encourages his patients to call the number 1-800-QUIT-NOW- to connect to state health departments, which provide nicotine replacement medications and trained counselors. Finally, Dr. Fankhauser discusses his smoking cessation research and emphasizes that it’s never too late for patients to stop smoking.

Disclaimer: The Materials available on are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Earn CME When You Listen to BackTable CMEfy

Up Next

Management of BCG-refractory NMIBC with Dr. Timothy Clinton and Dr. Eugene Pietzak on the BackTable Urology Podcast)
RPLND for Early Stage Testicular Cancer with Dr. Clint Cary and Dr. Timothy Masterson on the BackTable Urology Podcast)
Blue Light Cystoscopy: Who, When, and How? with Dr. Anne Schuckman on the BackTable Urology Podcast)
Adjuvant Therapy for Advanced Kidney Cancer: Who, What, When with Dr. Rana McKay and Dr. Karim Bensalah on the BackTable Urology Podcast)
Techniques & Maneuvers for Optimal TURBT with Dr. Sam Chang on the BackTable Urology Podcast)
Breaking Down Upper Tract Malignancy with Dr. Katie Murray on the BackTable Urology Podcast)



Bladder Cancer Condition Overview
Learn about Urologic Oncology on BackTable Urology

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.